FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

GROENHUYSEN WILHELMUS CM	2. Issuer Name and Ticker or Trading Symbol

NovoCure Ltd [ NVCR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Financial Officer	
(Last)         (First)         (Middle)

C/O NOVOCURE INC.,, 20 VALLEY STREAM PARKWAY, SUITE 300	3. Date of Earliest Transaction (MM/DD/YYYY)

11/13/2019		
(Street)

MALVERN, PA 19355
(City)       (State)       (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Ordinary Shares 	11/13/2019 	 	M	  	10000 (1)	A	$3.44 	97179 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	7542 	D	$80.802 (2)	89637 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	2458 	D	$81.158 (3)	87179 	D 	 	
Ordinary Shares 	11/13/2019 	 	M	  	20000 (1)	A	$3.44 	107179 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	13668 	D	$80.717 (4)	93511 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	6332 	D	$81.125 (5)	87179 	D 	 	
Ordinary Shares 	11/13/2019 	 	M	  	10000 (1)	A	$7.03 	97179 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	7458 	D	$80.785 (6)	89721 	D 	 	
Ordinary Shares 	11/13/2019 	 	S	  	2542 	D	$81.158 (7)	87179 	D 	 	
Ordinary Shares 	11/14/2019 	 	M	  	5169 (1)	A	$3.44 	92348 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	600 	D	$80.682 (8)	91748 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	2805 	D	$81.662 (9)	88943 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	1764 	D	$82.498 (10)	87179 	D 	 	
Ordinary Shares 	11/14/2019 	 	M	  	20000 (1)	A	$3.44 	107179 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	2000 	D	$80.778 (11)	105179 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	10800 	D	$81.666 (12)	94379 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	7200 	D	$82.535 (13)	87179 	D 	 	
Ordinary Shares 	11/14/2019 	 	M	  	2407 (1)	A	$7.03 	89586 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	500 	D	$80.956 (14)	89086 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	1403 	D	$81.804 (15)	87683 	D 	 	
Ordinary Shares 	11/14/2019 	 	S	  	504 	D	$82.623 (16)	87179 	D 	 	

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
Options to Buy Ordinary Shares 	$3.44 	11/13/2019 	 	M 	  	  	10000  	 (17)	12/13/2021 	Ordinary Shares 	10000.0 	$0 	5169 	D 	 	
Options to Buy Ordinary Shares 	$3.44 	11/13/2019 	 	M 	  	  	20000  	 (17)	12/13/2021 	Ordinary Shares 	20000.0 	$0 	45832 	D 	 	
Options to Buy Ordinary Shares 	$7.03 	11/13/2019 	 	M 	  	  	10000  	 (17)	2/19/2023 	Ordinary Shares 	10000.0 	$0 	36386 	D 	 	
Options to Buy Ordinary Shares 	$3.44 	11/14/2019 	 	M 	  	  	5169  	 (17)	12/13/2021 	Ordinary Shares 	5169.0 	$0 	0 	D 	 	
Options to Buy Ordinary Shares 	$3.44 	11/14/2019 	 	M 	  	  	20000  	 (17)	12/13/2021 	Ordinary Shares 	20000.0 	$0 	25832 	D 	 	
Options to Buy Ordinary Shares 	$7.03 	11/14/2019 	 	M 	  	  	2407  	 (17)	2/19/2023 	Ordinary Shares 	2407.0 	$0 	33979 	D 	 	

Explanation of Responses:	
(1) 	Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.	
(2) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 7,542 shares in multiple trades at prices ranging from $80.07 to $81.06. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(3) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,458 shares in multiple trades at prices ranging from $81.08 to $81.34. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(4) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 13,668 shares in multiple trades at prices ranging from $80.00 to $81.00. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(5) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 6,332 shares in multiple trades at prices ranging from $81.01 to $81.36. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(6) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 7,458 shares in multiple trades at prices ranging from $80.06 to $81.06. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(7) 	On November 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,542 shares in multiple trades at prices ranging from $81.08 to $81.34. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(8) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 600 shares in multiple trades at prices ranging from $80.13 to $81.09. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(9) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,805 shares in multiple trades at prices ranging from $81.14 to $82.11. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(10) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,764 shares in multiple trades at prices ranging from $82.18 to $82.80. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(11) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,000 shares in multiple trades at prices ranging from $80.13 to $81.09. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(12) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 10,800 shares in multiple trades at prices ranging from $81.13 to $82.12. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(13) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 7,200 shares in multiple trades at prices ranging from $82.13 to $82.89. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(14) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 500 shares in multiple trades at prices ranging from $80.37 to $81.34. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(15) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,403 shares in multiple trades at prices ranging from $81.46 to $82.44. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(16) 	On November 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 504 shares in multiple trades at prices ranging from $82.54 to $82.69. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.	
(17) 	Options exercised were fully vested as of the date hereof.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
GROENHUYSEN WILHELMUS CM
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN, PA 19355			Chief Financial Officer		

Signatures		
By: /s/ Todd Longsworth, Attorney in Fact for Wilhelmus CM Groenhuysen		11/15/2019	
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.